The present invention relates to the use of xenon in the preparation of amedicament for preventing and/or alleviating one or more anesthetic-inducedneurological deficits in a neonatal subject. The present invention furtherrelates to combinations of xenon and sevoflurane, and use thereof aspreconditioning agents for administration prior to hypoxic-ischaemic injury.